Sabine Schumann
Head of Communications
EIT Health

Successes Listed

Next-level Alzheimer’s screening
Bringing mobile technologies to everyday practice
RAS-Q: The lung in a backpack
Treating cancer using anti-Myc peptides
Sustainable course: Advanced Management Programme on Health Innovation
Systematically improving chronic joint pain management across Europe
Removing bottlenecks that prevent use of Antibody Drug Conjugates
Non-invasive neural stimulator for movement disorders
Online course equips online learners to maximise healthcare data
Eliminating pneumothorax during lung biopsy
Innovating to solve global health challenges
Bringing intelligence to genetic data
An artificial pancreas for Type 1 diabetes patients
Self-management systems for respiratory diseases
Smart software for healthcare support
Innovative design-based methods in the workplace
Hundreds of citizens learn about health and active ageing, and provide essential feedback
Summer school using real-life cases to catalyse innovation finds new funders
A collaborative approach to innovation in diabetes care
Citizen-centred training for healthcare professionals
Improving the measurement of joint mobility
A more natural solution to chronic constipation
Clinical Innovation Fellowship spin-off seeks to improve medical tube success
Driving health innovation for the future
Empowering women entrepreneurs in health innovation
Smart-up Lab students and other present their ideas to investors
Improved prostate cancer diagnostics
State-of-the-art tool for dementia risk assessment
Device offers inexpensive alternative to surgery for common prostate problem
New platform allows everyone to link and mine life-changing data faster, smarter and simpler
Developing next-generation biological drugs for treating wounds in skin and mucosa
Non-medicinal soft robotic for the best night’s rest
A Star-Trek like medical device that provides the solution to killing multiresistant bacteria and treating chronic wounds

Success Stories

Back

TADA Medical

TADA Medical

Clinical Innovation Fellowship spin-off seeks to improve medical tube success

08 December 2017
Header Image
TADA Medical is a spin-off company from a Campus programme, EIT Health Clinical Innovation Fellowship in Stockholm. TADA Medical was founded by the four original members of the multidisciplinary fellowship team in 2016. The team members have backgrounds in medicine, design, technology and management.

During their fellowship period, the team came across the huge need for safer medical tubes. As they investigated the need further, they learned about how widespread tube-related incidents were across clinical hospitals. Using their combined skills, the team has developed a fail-safe connector that protects the patient and medical tube from damage.

Until recently, the project was focused on development and testing of prototypes. The final design is now established with the first series of injection-moulded connectors being manufactured at the end of 2017. The following test phase will provide data for the technical file required by the CE-mark process.

TADA Medical belongs to the KTH Innovation pre-incubator and has been granted €309,000 in soft funding to date. In November 2017, the company also won the Senior Category in the Showcase Innovation Fellowship Alumni Competition.

Innovation

All medical tubes are constantly in danger of being dislodged. Dislodgement occurs when the medical tube is accidentally subjected to a force large enough to cause is to detach from the patient, thereby pulling away any dressing, needle or other fastening and/or access device.

There are many different consequences of accidental dislodgement, including:

  • increased risk of needle stick injury for medical staff due to needle replacement
  • interrupted intravenous therapy
  • increased medical staff workload and additional cost for each restarted therapy
  • exposure of patients and medical staff to leaking liquids
  • wasting expensive medication
  • substantial blood loss in unconscious and unaware patients

Approximately eight out of ten patients entering the hospital will receive a medical tube for infusion. Clinical studies show an average infusion failure rate of 10% due to dislodgement. For some patient groups, the failure rate is as high as 30%. An average infusion restart costs €25. For a medium sized hospital, this will lead to unnecessary healthcare costs of approximately €90,000 per year due to dislodged infusions alone.

TADAS’s patent pending connector is placed on the medical tube close to the patient’s vascular access site. It is designed to separate into two parts when the tube is pulled. The double valve feature keeps any liquid from spilling which is especially important when considering chemotherapy treatment or blood diseases.

All medical tubes used for infusion, transfusion and dialysis would benefit from the TADA connector. Other medical tubes that would profit from the TADA connector are urinary catheters and drains.

Benefits of EIT Health support

Katarina Hedbeck, CEO said EIT Health support has been invaluable: “The team is immensely grateful for having had the opportunity to participate in the Innovation Fellowship. If it were not for the programme, the four of us would never have met. Also, the programme provided us with support and a platform enabling them to kick-start their company.

"The EIT Health HeadStart/Proof-of-Concept grant for €50,000 has been invaluable for the company. Product development within the medical technology field requires great knowledge in risk analysis, quality management and intellectual property rights – all of which TADA have taken consultant advice for. This would not have been possible without the financial support of EIT Health.”

Partners

KTH, Royal Institute of Technology

Contact: info@tadamedical.com

Web: www.tadamedical.com